Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia 40Leukemia, Myeloid, Acute 24Congenital Abnormalities 22Leukemia, Lymphocytic, Chronic, B-Cell 16Breast Neoplasms 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Follicular 14Lymphoma, B-Cell, Marginal Zone 14Lymphoma, Mantle-Cell 12Myelodysplastic Syndromes 11Multiple Myeloma 10Lymphoma, Non-Hodgkin 10Lymphoma, Large B-Cell, Diffuse 10Leukemia, Megakaryoblastic, Acute 10Myeloproliferative Disorders 9Lymphoma 9Leukemia, Monocytic, Acute 9Leukemia, Erythroblastic, Acute 9Burkitt Lymphoma 9Lymphoma, Large-Cell, Immunoblastic 8Leukemia, Myelomonocytic, Chronic 8Leukemia, Myelomonocytic, Acute 8Leukemia, Myeloid, Chronic-Phase 8Waldenstrom Macroglobulinemia 7Sezary Syndrome 7Neoplastic Cells, Circulating 7Mycosis Fungoides 7Melanoma 7Lymphoma, T-Cell, Cutaneous 7Lung Neoplasms 7

Interventions

Carboplatin 41Paclitaxel 40pembrolizumab 38Cyclophosphamide 23Gemcitabine 22130-nm albumin-bound paclitaxel 21Doxorubicin 18Cisplatin 18Albumin-Bound Paclitaxel 18atezolizumab 16Taxes 15Capecitabine 13veliparib 10Nivolumab 9Docetaxel 9Bevacizumab 9olaparib 8liposomal doxorubicin 7Everolimus 7spartalizumab 6durvalumab 6Epirubicin 6trametinib 5pegfilgrastim 5eribulin 5Irinotecan 5Filgrastim 5iniparib 4binimetinib 4apatinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Triple Negative Breast Neoplasms × Flow Cytometry × Clear all
NCT00986609 2018-07-23

MUC1 Vaccine for Triple-negative Breast Cancer

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
29 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡